ArticleCardiovascular diabetology2025
Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices.
Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis.Cardiovascular diabetology · 2026Pooled it
- The association between weight-adjusted waist circumference index and risks of cardiovascular and all-cause mortality: a retrospective analysis based on the NHANES database.Annals of medicine · 2026Article
- Anthropometry-adjusted TyG indices predict diabetes, graft failure, and mortality in kidney transplant recipients.Journal of the Endocrine Society · 2026Article
- Joint longitudinal trajectories of the triglyceride-glucose index combined with BMI and waist-to-height ratio and incident cardiovascular disease: a prospective cohort study from the English longitudinal study of ageing.Cardiovascular diabetology · 2026Article
- Systematic comparison of triglyceride-glucose (TYG)-index with other mortality predictive models in obese patients with different mortality rates.Cardiovascular diabetology · 2026Article
- Triglyceride-glucose waist-to-height ratio improves risk stratification for depressive symptoms: evidence from NHANES.European archives of psychiatry and clinical neuroscience · 2026Article
- Evaluation of the lipid accumulation product for MASLD risk stratification in type 2 diabetes: establishing sex-specific thresholds and clinical utility.Cardiovascular diabetology · 2026Article
- Predicting time to glycemic stability in hospitalized type 2 diabetes patients using insulin resistance indices: a nomogram development and validation study.Endocrine connections · 2026Article
- Association of various insulin resistance surrogate markers with mortality risk in critically ill patients with ischemic stroke: a retrospective cohort study.Cardiovascular diabetology · 2026Article
- Associations of eight insulin resistance-related indices and genetic risk with incident cardiometabolic multimorbidity among participants with hypertension: a large prospective cohort study.Cardiovascular diabetology · 2026Observational
- Association between triglyceride-glucose index and related indicators with heart failure-related mortality in individuals with early-stage cardiovascular-kidney-metabolic syndrome.Cardiovascular diabetology · 2026Article
- Triglyceride-glucose index and mortality in critically ill patients with cardiovascular-kidney-metabolic syndrome stage 4.Cardiovascular diabetology · 2026Article
- Simplicity meets accuracy: TyG-Waist as a practical alternative to CVAI for type 2 diabetes prediction in high-risk Chinese adults.BMC endocrine disorders · 2026Article
- A machine learning model based on routine blood-derived indices for early arterial stiffness prediction in the community.Lipids in health and disease · 2026Article
- Coronary heart disease offspring: identification of short-term cardiovascular risk factors and construction of digital technology-integrated personalized health education pathways.BMC cardiovascular disorders · 2026Article
- Article
- Triglyceride-glucose-related indices and cardiovascular outcomes in individuals with pre-frailty or frailty: insights from a prospective cohort analysis using UK Biobank data.Cardiovascular diabetology · 2026Article
- Association of novel triglyceride-glucose index-derived indices with hyperuricemia among oilfield workers.Frontiers in nutrition · 2026Article
- Machine learning model based on routine blood and biochemical parameters for early diagnosis of diabetic kidney disease.Frontiers in endocrinology · 2026Article
- Association of the TyG index and its body fat distribution composites with CHD and MACE risk in adults with OSAHS: incremental discrimination and exploratory mediation analysis.Frontiers in endocrinology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundCardiovascular disease (CVD) remains the leading cause of mortality worldwide, emphasizing the need for enhanced risk stratification tools. The triglyceride‒glucose-weight adjusted waist index (TyG-WWI), which integrates insulin resistance and central obesity, has emerged as a potential predictor, but its performance relative to traditional TyG-related indices (TyG, TyG-WC, TyG-WHtR) requires further validation.
methodsWe analyzed data from 24,255 participants in the National Health and Nutrition Examination Survey (NHANES, 1999-2018). Weighted Cox proportional hazards models were used to assess the associations between TyG-related indices and cardiovascular mortality. Restricted cubic splines (RCSs) with four knots were employed to explore dose‒response relationships. Traditional and time-dependent receiver operating characteristic (ROC) analyses, net reclassification improvement (NRI) analyses, and subgroup and sensitivity analyses were conducted to evaluate predictive performance and robustness.
resultsOver a median follow-up of 9.67 years, 854 cardiovascular deaths were recorded. According to the fully adjusted models, each increase in the standard deviation of the TyG-WWI was associated with a 45% greater risk of cardiovascular mortality (HR = 1.45, 95% CI 1.31-1.60), which was stronger than the associations observed for TyG (HR = 1.24, 95% CI 1.12-1.38), TyG-WC (HR = 1.39, 95% CI 1.27-1.53), and TyG-WHtR (HR = 1.43, 95% CI 1.30-1.58). When stratified by quartiles, the TyG-WWI exhibited a clear dose‒response relationship. RCS analyses revealed that the TyG-WWI had a linear association with cardiovascular mortality (P-nonlinear = 0.491), whereas the TyG index exhibited a U-shaped association, and the TyG-WC index and TyG-WHtR showed L-shaped associations (all P-nonlinear < 0.05). Traditional ROC analysis revealed that the TyG-WWI had the highest AUC (0.694, 95% CI 0.678-0.710). Time-dependent ROC analyses demonstrated that the AUC for the TyG-WWI ranged from 0.706 to 0.751 across different follow-up time points, which was consistently greater than those of the other TyG-related indices. NRI analyses indicated significant improvements in risk reclassification when the TyG-WWI was used compared with traditional TyG-related indices (10.4% vs. TyG, 9.4% vs. TyG-WC, 9.1% vs. TyG-WHtR). Subgroup analyses revealed stronger associations in younger adults (≤ 60 years, HR = 2.03, 95% CI 1.78-2.32).
conclusionThe current study is the first to validate that the TyG-WWI is a reliable risk prediction tool for cardiovascular death in the general population and has greater predictive value than traditional TyG-related parameters. The results support its potential as a supplementary tool among TyG-derived markers for assessing cardiovascular death.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.